Sam***ara

Deal Execution, Strategic Communications, Search & Evaluation, Negotiation

Corporate Development at Gilead Sciences

• Location: San Francisco Bay Area
• Duration: 2021-07 to Present
• Description: Combining strong scientific expertise with strategic biotech business acumen to drive diligence and transactions. Technical diligence, deal structuring and contracting for both pre-clinical & clinical stage platforms & assets: mergers & acquisitions, research collaborations, licensing deals and investments. Management of Gilead's engagements with venture capital firms. Focused on next-gen platforms (wet lab & computational) with the potential to accelerate small molecule drug discovery, protein therapeutics, and emerging modalities for cancer, immunology and virology. Selected Deal Experience (Includes both transactional & scientific diligence) - Dragonfly Therapeutics; $300M upfront - License & Option, Multi-target - Tentarix Therapeutics; $66M upfront - Option to Acquire, Equity investment, Multi-target - Genesis Therapeutics; $35M upfront - Small Molecule Discovery, Generative AI, Multi-target - Cartography Biosciences; $20M upfront - Target Discovery, Single-cell Genomics, Multi-target - Terray Therapeutics; Undisclosed $ - Small Molecule Discovery, Nanotech + AI, Multi-target - A-Alpha Bio; Undisclosed $ - Large Molecule Discovery, Machine Learning/Synthetic Bio - AbTherx; Undisclosed $ - Antibody Discovery Platform - Biocytogen; Undisclosed $ - Antibody Discovery Platform

Co-Founder & Alumni Editor in Chief at Yale Africa Startup Review

• Location:
• Duration: 2021-03 to Present
• Description: The Yale Africa Startup Review is a student and alumni-led initiative featuring founders and startups shaping the future of Africa with entrepreneurship. Our mission is to share stories of ingenuity and innovation to attract interested stakeholders to the African startup ecosystem. We engage with the continent’s most active & innovative venture capital firms and ecosystem partners. https://www.yasr.org/

Corporate Finance at Gilead Sciences

• Location: Foster City, California, United States
• Duration: 2020-08 to 2021-07
• Description: Corporate risk governance & controls (financial, technology, business conduct & operational controls)

Researcher at Broad Institute of MIT and Harvard

• Location:
• Duration: 2014-08 to 2018-08
• Description: Targeted therapies & drug delivery in T-cell Acute Lymphoblastic Leukemia (Published in the Journal of Experimental Medicine) Epigenetic resistance to cancer therapeutics in Neuroblastoma (Published in Cancer Cell) Blockade of gain-of-function mutations in NOTCH-driven liquid tumors (Published in Cell Chemical Biology) Targeted therapy & genomic characterization in Hepatosplenic T-cell Lymphoma (Published in Blood Advances) Targeted strategies for serine metabolism in Leukemia (Published - Leukemia, Nature Publishing) Epigenetic dependencies in T-Cell Acute Lymphoblastic Leukemia (Published - Cell Death & Disease, Nature Publishing)

Researcher at Dana-Farber Cancer Institute, Harvard Medical School

• Location:
• Duration: 2014-08 to 2018-08
• Description: - Targeted therapies & drug delivery in T-cell Acute Lymphoblastic Leukemia (Published in the Journal of Experimental Medicine) - Epigenetic resistance to cancer therapeutics in Neuroblastoma (Published in Cancer Cell) - Blockade of gain-of-function mutations in NOTCH-driven liquid tumors (Published in Cell Chemical Biology) - Targeted therapy & genomic characterization in Hepatosplenic T-cell Lymphoma (Published in Blood Advances) - Targeted strategies for serine metabolism in Leukemia (Published - Leukemia, Nature Publishing) - Epigenetic dependencies in T-Cell Acute Lymphoblasitc Leukemia (Published - Cell Death & Disease, Nature Publishing)